💨 Abstract

Amneal Pharmaceuticals reported a first-quarter net income of $12.2 million, beating Wall Street expectations, with earnings of 21 cents per share. However, revenue of $695.4 million was lower than forecasted. The company expects full-year earnings between 65 cents and 70 cents per share and revenue between $3 billion and $3.1 billion.

Courtesy: wtop.com

Summarized by Einstein Beta 🤖